MISSOURI CITY, Texas – April 10, 2002 – The Texas Board of Chiropractic Examiners has determined that MicroLight Corporation of America’s ML 830® low-level laser is within the scope of chiropractic care, the company announced today.
« This represents a major breakthrough in the treatment of Carpal Tunnel Syndrome in the chiropractic profession, » said MicroLight President Mike Barbour. « This will allow more than 4,000 chiropractors in the state of Texas access to the ML 830® patented laser technology. »
MicroLight is the only company that has received FDA clearance to market low-level laser therapy for non-surgical treatment of Carpal Tunnel Syndrome, or CTS. CTS is the No. 1 repetitive-stress injury problem in the workforce, costing the U.S. health care industry more than $10 billion annually.